Alocane Plus Gel
NDC Package 68229-300-06
Package Information
Alocane Plus (lidocaine hydrochloride and benzalkonium chloride) gel is adults and children 2 years of age and older: Apply to affected areas not more than 3 to 4 times daily. This formulation utilizes a gel delivery system. Marketed by Quest Products Llc, this product is identified by NDC 68229-300 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2375042 - benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel
- RxCUI: 2375042 - benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel
- RxCUI: 2587646 - ALOCANE plus 4 % / 0.13 % Topical Gel
- RxCUI: 2587646 - benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus]
- RxCUI: 2587646 - Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 68229 - Quest Products Llc
- 68229-300 - Alocane Plus
- 68229-300-06 - 48 DOSE PACK in 1 CARTON / 3.55 mL in 1 DOSE PACK (68229-300-05)
- 68229-300 - Alocane Plus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68229-300). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68229-300-06 identifies a specific commercial package of 48 dose pack in 1 carton / 3.55 ml in 1 dose pack (68229-300-05) of Alocane Plus, a human over the counter drug labeled by Quest Products Llc. This gel is formulated for topical use and contains benzalkonium chloride; lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Quest Products Llc on May 01, 2020. The current certification is valid through December 31, 2026.
How is this Quest Products Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68229030006. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.